Genscript Biotech Corporation
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
0/10
|
0 | 35.42 | -100% | -262.31 | -100% |
| P/S |
|
6.18 | 7.59 | -18.52% |
|
|
| P/BV |
|
2.54 | 3.68 | -31.1% |
|
|
| P/FCF |
|
-94.03 | 55.3 | -270.06% |
|
|
| Ev/Ebitda |
|
-93.49 | 2.91 | -3315.04% |
|
|
| Ev/S |
|
39.44 | 23.72 | 66.3% |
|
|
| Ev/FCF |
|
-74.47 | 63.78 | -216.76% |
|
|
| E/P |
|
-0.0023 | 0.0326 | -107.05% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
0/10
|
-56.6 | -11.9 | 375.57% | -46.49 | +21.75% |
| ROE |
|
-7.95 | 5.19 | -253.3% |
|
|
| ROA |
|
-3.22 | 3.47 | -192.75% |
|
|
| ROIC |
|
0 | 0 | 0% |
|
|
| ROS |
|
-11.37 | -11.49 | -1.02% |
|
|
| ROCE |
|
0 | 6.04 | -100% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
10/10
|
-1.85 | 0.7755 | -338.82% | -2.65 | -30.1% |
| Nеt Debt/Ebitda |
|
0 | 0.0127 | -100% |
|
|
| Debt/Ratio |
|
0.1937 | 0.1229 | 57.64% |
|
|
| Debt/Equity |
|
1.01 | 0.802 | 26.44% |
|
|
| Debt/Net Income |
|
-6.87 | 1.76 | -490.93% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
0/10
|
0 | 5.7 | -100% | 0.1972 | -100% |
| Number of years of dividend growth |
|
1 | 1.13 | -11.11% | ||
| DSI |
|
0.5 | 0.5838 | -14.35% |
|
|
| Average dividend growth |
|
0 | 3.2 | -100% |
|
|
| Average percentage for 5 years |
|
0.1972 | 4.95 | -96.02% |
|
|
| Average percentage for payments |
|
19.33 | 23.96 | -19.33% |
|
|
| Difference from average difference in sector |
|
-5.7 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
10/10
|
207.12 | 28.69 | 621.92% | ||
| Growth impulse Ebitda in 5 years |
|
-309.46 | -40.52 | 663.72% | ||
| Growth impulse Net Income in 5 years |
|
-1.48 | 94.84 | -101.56% | ||
| Growth impulse FCF in 5 years |
|
199.43 | 91.41 | 118.17% | ||
| Growth impulse EPS in 5 years |
|
-88.8 | -118.14 | -24.83% |
IP Score
3.38/10
